IDEAYA Biosciences, Inc. (IDYA) /
The cash flow of IDEAYA Biosciences, Inc. over the past 9 years
Chart IDEAYA Biosciences, Inc.: operating cash flow, capital expenditures, free cash flow, fiscal 2017–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, IDEAYA Biosciences, Inc.'s operating cash flow was -$71.1M and its capital expenditures $2.37M, leaving free cash flow of -$73.47M. Free cash flow was above zero in 1 of the 9 years shown. It ranged from -$251.44M in fiscal 2024 to $54.97M in fiscal 2020. Capital expenditures were highest in fiscal 2024, at $3.86M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$71.1M | $2.37M | -$73.47M |
| 2024ended Dec 31, 2024 | -$247.58M | $3.86M | -$251.44M |
| 2023ended Dec 31, 2023 | -$115.22M | $2.37M | -$117.59M |
| 2022ended Dec 31, 2022 | -$87.17M | $3.44M | -$90.62M |
| 2021ended Dec 31, 2021 | -$55.78M | $2.64M | -$58.42M |
| 2020ended Dec 31, 2020 | $55.46M | $493K | $54.97M |
| 2019ended Dec 31, 2019 | -$39.31M | $1.35M | -$40.67M |
| 2018ended Dec 31, 2018 | -$27.62M | $1.71M | -$29.33M |
| 2017ended Dec 31, 2017 | -$12.22M | $1.76M | -$13.98M |
Fiscal years as IDEAYA Biosciences, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on IDEAYA Biosciences, Inc.
- The revenue of IDEAYA Biosciences, Inc.
- The profitability of IDEAYA Biosciences, Inc.
- The debt of IDEAYA Biosciences, Inc.
- All of IDEAYA Biosciences, Inc.'s financials, charted
Companies of a similar size
- USLMUNITED STATES LIME & MINERALS INC
- ABMABM INDUSTRIES INCORPORATED
- MHOM/I HOMES, INC.
- GBDCGolub Capital BDC, Inc.
- FIVNFive9, Inc.
Not investment advice. This page shows what IDEAYA Biosciences, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.